Pharmacy Benefit Management Market By Service (Specialty Pharmacy, Drug Formulatory Management, Benefit Plan Design and Consultation, Other Services) , By Business Model (Government Health Programs, Employer-Sponsored Programs, Health Insurance Management) By End User (Pharmacy Benefit Management Organization, Mail Order Pharmacies, Retail Pharmacies, Other) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Pharmacy Benefit Management Market
The pharmacy benefit management market was valued at $0.5 billion in 2023 and is projected to reach $1.0 billion by 2033, growing at a CAGR of 6.1% from 2024 to 2033.
Pharmacy benefit management (PBM) is a third-party administrator that plays a crucial role in the healthcare system as it acts as an intermediary between drug manufacturers, pharmacies, and health insurance companies. The role of PBM is to regulate prescription drug benefits for patients to control the surging medication costs, while ensuring access to essential treatments.
Rise in healthcare expenses is a key driver of the pharmacy benefit management market as PBMs effectively control the expenditure on drugs by the implementation of strategies such as formulary management and negotiating rebates. Furthermore, the ability of PBMs to ensure transparency in healthcare costs augments the development of the market significantly. To accelerate decision-making, the usage of data analytics tools is trending in the market. These tools use advanced analytics techniques for cost optimization, pattern identification in prescription drug usage, and favorable pricing negotiation with pharmaceutical manufacturers.
However, concerns pertaining to privacy of the personal health information of patients deter several individuals from availing services of PBMs, hampering the development of the market. Furthermore, as the pharmacy benefit management market is highly concentrated, the dominating companies hold maximum power to gain excessive total compensation from their customers. This power restrains the growth of the market. For instance, three firms controlled 79% of the U.S. market in 2022, offering them the authority to earn excessive profits. Contrarily, the integration of PBM services with telemedicine and digital health solutions is poised to present lucrative opportunities for the market expansion.
Segment Review
The pharmacy benefit management market is segmented into service, business model, end user, and region. On the basis of service, the market is divided into specialty pharmacy, drug formulatory management, benefit plan design & consultation, and other services. Depending on business model, it is classified into government health programs, employer-sponsored programs, and health insurance management. As per end user, it is categorized into pharmacy benefit management organization, mail order pharmacies, retail pharmacies, and other. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of service, the specialty pharmacy segment is expected to dominate the market throughout the forecast period.
Depending on business model, the health insurance management segment is projected to acquire a high stake in the market by 2033.
As per end user, the pharmacy benefit management organization segment is predicted to be the highest shareholder during the forecast period.
Region wise, North America is anticipated to be the highest revenue generator by 2033.
Competition Analysis
The leading players operating in the global pharmacy benefit management market include CVS Health, The Cigna Group, OptumRx Inc., Anthem Inc, Centene Corporation, Abarca Health LLC, Medimpact, Elixir Rx Solutions LLC, Express Scripts Holding Company, and SS&C Technologies, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Key Market Segments
By Service
Specialty Pharmacy
Drug Formulatory Management
Benefit Plan Design and Consultation
Other Services
By Business Model
Government Health Programs
Employer-Sponsored Programs
Health Insurance Management
By End User
Pharmacy Benefit Management Organization
Mail Order Pharmacies
Retail Pharmacies
Other
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
CVS Health
The Cigna Group
OptumRx Inc
Anthem Inc
Centene Corporation
Abarca Health LLC
Medimpact
Elixir Rx Solutions LLC
Express Scripts Holding Company
SS&C Technologies, Inc
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Service
- 4.2. Specialty Pharmacy
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Drug Formulatory Management
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Benefit Plan Design And Consultation
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Other Services
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
- CHAPTER 5: PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Business Model
- 5.2. Government Health Programs
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Employer-Sponsored Programs
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Health Insurance Management
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- CHAPTER 6: PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Pharmacy Benefit Management Organization
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Mail Order Pharmacies
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Retail Pharmacies
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- 6.5. Other
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
- CHAPTER 7: PHARMACY BENEFIT MANAGEMENT MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Service
- 7.2.3. Market Size and Forecast, By Business Model
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Pharmacy Benefit Management Market
- 7.2.6.1. Market Size and Forecast, By Service
- 7.2.6.2. Market Size and Forecast, By Business Model
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Pharmacy Benefit Management Market
- 7.2.7.1. Market Size and Forecast, By Service
- 7.2.7.2. Market Size and Forecast, By Business Model
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Pharmacy Benefit Management Market
- 7.2.8.1. Market Size and Forecast, By Service
- 7.2.8.2. Market Size and Forecast, By Business Model
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Service
- 7.3.3. Market Size and Forecast, By Business Model
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Pharmacy Benefit Management Market
- 7.3.6.1. Market Size and Forecast, By Service
- 7.3.6.2. Market Size and Forecast, By Business Model
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Pharmacy Benefit Management Market
- 7.3.7.1. Market Size and Forecast, By Service
- 7.3.7.2. Market Size and Forecast, By Business Model
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. UK Pharmacy Benefit Management Market
- 7.3.8.1. Market Size and Forecast, By Service
- 7.3.8.2. Market Size and Forecast, By Business Model
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Pharmacy Benefit Management Market
- 7.3.9.1. Market Size and Forecast, By Service
- 7.3.9.2. Market Size and Forecast, By Business Model
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Pharmacy Benefit Management Market
- 7.3.10.1. Market Size and Forecast, By Service
- 7.3.10.2. Market Size and Forecast, By Business Model
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Pharmacy Benefit Management Market
- 7.3.11.1. Market Size and Forecast, By Service
- 7.3.11.2. Market Size and Forecast, By Business Model
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Service
- 7.4.3. Market Size and Forecast, By Business Model
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Pharmacy Benefit Management Market
- 7.4.6.1. Market Size and Forecast, By Service
- 7.4.6.2. Market Size and Forecast, By Business Model
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Pharmacy Benefit Management Market
- 7.4.7.1. Market Size and Forecast, By Service
- 7.4.7.2. Market Size and Forecast, By Business Model
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. Australia Pharmacy Benefit Management Market
- 7.4.8.1. Market Size and Forecast, By Service
- 7.4.8.2. Market Size and Forecast, By Business Model
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. India Pharmacy Benefit Management Market
- 7.4.9.1. Market Size and Forecast, By Service
- 7.4.9.2. Market Size and Forecast, By Business Model
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Pharmacy Benefit Management Market
- 7.4.10.1. Market Size and Forecast, By Service
- 7.4.10.2. Market Size and Forecast, By Business Model
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Pharmacy Benefit Management Market
- 7.4.11.1. Market Size and Forecast, By Service
- 7.4.11.2. Market Size and Forecast, By Business Model
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Service
- 7.5.3. Market Size and Forecast, By Business Model
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Pharmacy Benefit Management Market
- 7.5.6.1. Market Size and Forecast, By Service
- 7.5.6.2. Market Size and Forecast, By Business Model
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. Saudi Arabia Pharmacy Benefit Management Market
- 7.5.7.1. Market Size and Forecast, By Service
- 7.5.7.2. Market Size and Forecast, By Business Model
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. South Africa Pharmacy Benefit Management Market
- 7.5.8.1. Market Size and Forecast, By Service
- 7.5.8.2. Market Size and Forecast, By Business Model
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Pharmacy Benefit Management Market
- 7.5.9.1. Market Size and Forecast, By Service
- 7.5.9.2. Market Size and Forecast, By Business Model
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. CVS Health
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. The Cigna Group
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. OptumRx Inc
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Anthem Inc
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Centene Corporation
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Abarca Health LLC
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Medimpact
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Elixir Rx Solutions LLC
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Express Scripts Holding Company
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. SSAndC Technologies, Inc
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. GLOBAL PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 2. PHARMACY BENEFIT MANAGEMENT MARKET FOR SPECIALTY PHARMACY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. PHARMACY BENEFIT MANAGEMENT MARKET FOR DRUG FORMULATORY MANAGEMENT, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. PHARMACY BENEFIT MANAGEMENT MARKET FOR BENEFIT PLAN DESIGN AND CONSULTATION, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. PHARMACY BENEFIT MANAGEMENT MARKET FOR OTHER SERVICES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. GLOBAL PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 7. PHARMACY BENEFIT MANAGEMENT MARKET FOR GOVERNMENT HEALTH PROGRAMS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. PHARMACY BENEFIT MANAGEMENT MARKET FOR EMPLOYER-SPONSORED PROGRAMS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. PHARMACY BENEFIT MANAGEMENT MARKET FOR HEALTH INSURANCE MANAGEMENT, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. GLOBAL PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 11. PHARMACY BENEFIT MANAGEMENT MARKET FOR PHARMACY BENEFIT MANAGEMENT ORGANIZATION, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. PHARMACY BENEFIT MANAGEMENT MARKET FOR MAIL ORDER PHARMACIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. PHARMACY BENEFIT MANAGEMENT MARKET FOR RETAIL PHARMACIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. PHARMACY BENEFIT MANAGEMENT MARKET FOR OTHER, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. PHARMACY BENEFIT MANAGEMENT MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 16. NORTH AMERICA PHARMACY BENEFIT MANAGEMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 17. NORTH AMERICA PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 18. NORTH AMERICA PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 19. NORTH AMERICA PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 20. U.S. PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 21. U.S. PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 22. U.S. PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 23. CANADA PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 24. CANADA PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 25. CANADA PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 26. MEXICO PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 27. MEXICO PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 28. MEXICO PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 29. EUROPE PHARMACY BENEFIT MANAGEMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 30. EUROPE PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 31. EUROPE PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 32. EUROPE PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 33. GERMANY PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 34. GERMANY PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 35. GERMANY PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 36. FRANCE PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 37. FRANCE PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 38. FRANCE PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 39. UK PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 40. UK PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 41. UK PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 42. ITALY PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 43. ITALY PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 44. ITALY PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 45. SPAIN PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 46. SPAIN PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 47. SPAIN PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 48. REST OF EUROPE PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 49. REST OF EUROPE PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 50. REST OF EUROPE PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 51. ASIA-PACIFIC PHARMACY BENEFIT MANAGEMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 52. ASIA-PACIFIC PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 53. ASIA-PACIFIC PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 54. ASIA-PACIFIC PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 55. JAPAN PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 56. JAPAN PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 57. JAPAN PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 58. CHINA PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 59. CHINA PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 60. CHINA PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 61. AUSTRALIA PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 62. AUSTRALIA PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 63. AUSTRALIA PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 64. INDIA PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 65. INDIA PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 66. INDIA PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 67. SOUTH KOREA PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 68. SOUTH KOREA PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 69. SOUTH KOREA PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 70. REST OF ASIA-PACIFIC PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 71. REST OF ASIA-PACIFIC PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 72. REST OF ASIA-PACIFIC PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 73. LAMEA PHARMACY BENEFIT MANAGEMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 74. LAMEA PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 75. LAMEA PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 76. LAMEA PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 77. BRAZIL PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 78. BRAZIL PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 79. BRAZIL PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 80. SAUDI ARABIA PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 81. SAUDI ARABIA PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 82. SAUDI ARABIA PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 83. SOUTH AFRICA PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 84. SOUTH AFRICA PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 85. SOUTH AFRICA PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 86. REST OF LAMEA PHARMACY BENEFIT MANAGEMENT MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 87. REST OF LAMEA PHARMACY BENEFIT MANAGEMENT MARKET, BY BUSINESS MODEL, 2024 - 2033 ($BILLION)
- TABLE 88. REST OF LAMEA PHARMACY BENEFIT MANAGEMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 89. CVS HEALTH: KEY EXECUTIVES
- TABLE 90. CVS HEALTH: COMPANY SNAPSHOT
- TABLE 91. CVS HEALTH: OPERATING SEGMENTS
- TABLE 92. CVS HEALTH: PRODUCT PORTFOLIO
- TABLE 93. CVS HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 94. THE CIGNA GROUP: KEY EXECUTIVES
- TABLE 95. THE CIGNA GROUP: COMPANY SNAPSHOT
- TABLE 96. THE CIGNA GROUP: OPERATING SEGMENTS
- TABLE 97. THE CIGNA GROUP: PRODUCT PORTFOLIO
- TABLE 98. THE CIGNA GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 99. OPTUMRX INC: KEY EXECUTIVES
- TABLE 100. OPTUMRX INC: COMPANY SNAPSHOT
- TABLE 101. OPTUMRX INC: OPERATING SEGMENTS
- TABLE 102. OPTUMRX INC: PRODUCT PORTFOLIO
- TABLE 103. OPTUMRX INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 104. ANTHEM INC: KEY EXECUTIVES
- TABLE 105. ANTHEM INC: COMPANY SNAPSHOT
- TABLE 106. ANTHEM INC: OPERATING SEGMENTS
- TABLE 107. ANTHEM INC: PRODUCT PORTFOLIO
- TABLE 108. ANTHEM INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 109. CENTENE CORPORATION: KEY EXECUTIVES
- TABLE 110. CENTENE CORPORATION: COMPANY SNAPSHOT
- TABLE 111. CENTENE CORPORATION: OPERATING SEGMENTS
- TABLE 112. CENTENE CORPORATION: PRODUCT PORTFOLIO
- TABLE 113. CENTENE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 114. ABARCA HEALTH LLC: KEY EXECUTIVES
- TABLE 115. ABARCA HEALTH LLC: COMPANY SNAPSHOT
- TABLE 116. ABARCA HEALTH LLC: OPERATING SEGMENTS
- TABLE 117. ABARCA HEALTH LLC: PRODUCT PORTFOLIO
- TABLE 118. ABARCA HEALTH LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 119. MEDIMPACT: KEY EXECUTIVES
- TABLE 120. MEDIMPACT: COMPANY SNAPSHOT
- TABLE 121. MEDIMPACT: OPERATING SEGMENTS
- TABLE 122. MEDIMPACT: PRODUCT PORTFOLIO
- TABLE 123. MEDIMPACT: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 124. ELIXIR RX SOLUTIONS LLC: KEY EXECUTIVES
- TABLE 125. ELIXIR RX SOLUTIONS LLC: COMPANY SNAPSHOT
- TABLE 126. ELIXIR RX SOLUTIONS LLC: OPERATING SEGMENTS
- TABLE 127. ELIXIR RX SOLUTIONS LLC: PRODUCT PORTFOLIO
- TABLE 128. ELIXIR RX SOLUTIONS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 129. EXPRESS SCRIPTS HOLDING COMPANY: KEY EXECUTIVES
- TABLE 130. EXPRESS SCRIPTS HOLDING COMPANY: COMPANY SNAPSHOT
- TABLE 131. EXPRESS SCRIPTS HOLDING COMPANY: OPERATING SEGMENTS
- TABLE 132. EXPRESS SCRIPTS HOLDING COMPANY: PRODUCT PORTFOLIO
- TABLE 133. EXPRESS SCRIPTS HOLDING COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 134. SSANDC TECHNOLOGIES, INC: KEY EXECUTIVES
- TABLE 135. SSANDC TECHNOLOGIES, INC: COMPANY SNAPSHOT
- TABLE 136. SSANDC TECHNOLOGIES, INC: OPERATING SEGMENTS
- TABLE 137. SSANDC TECHNOLOGIES, INC: PRODUCT PORTFOLIO
- TABLE 138. SSANDC TECHNOLOGIES, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. GLOBAL PHARMACY BENEFIT MANAGEMENT MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF PHARMACY BENEFIT MANAGEMENT MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN PHARMACY BENEFIT MANAGEMENT MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPHARMACY BENEFIT MANAGEMENT MARKET
- FIGURE 10. GLOBAL PHARMACY BENEFIT MANAGEMENT MARKET SEGMENTATION, BY SERVICE
- FIGURE 11. PHARMACY BENEFIT MANAGEMENT MARKET FOR SPECIALTY PHARMACY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. PHARMACY BENEFIT MANAGEMENT MARKET FOR DRUG FORMULATORY MANAGEMENT, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. PHARMACY BENEFIT MANAGEMENT MARKET FOR BENEFIT PLAN DESIGN AND CONSULTATION, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. PHARMACY BENEFIT MANAGEMENT MARKET FOR OTHER SERVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. GLOBAL PHARMACY BENEFIT MANAGEMENT MARKET SEGMENTATION, BY BUSINESS MODEL
- FIGURE 16. PHARMACY BENEFIT MANAGEMENT MARKET FOR GOVERNMENT HEALTH PROGRAMS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. PHARMACY BENEFIT MANAGEMENT MARKET FOR EMPLOYER-SPONSORED PROGRAMS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. PHARMACY BENEFIT MANAGEMENT MARKET FOR HEALTH INSURANCE MANAGEMENT, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. GLOBAL PHARMACY BENEFIT MANAGEMENT MARKET SEGMENTATION, BY END USER
- FIGURE 20. PHARMACY BENEFIT MANAGEMENT MARKET FOR PHARMACY BENEFIT MANAGEMENT ORGANIZATION, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. PHARMACY BENEFIT MANAGEMENT MARKET FOR MAIL ORDER PHARMACIES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. PHARMACY BENEFIT MANAGEMENT MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 23. PHARMACY BENEFIT MANAGEMENT MARKET FOR OTHER, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 24. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 25. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 26. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 27. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 28. COMPETITIVE DASHBOARD
- FIGURE 29. COMPETITIVE HEATMAP: PHARMACY BENEFIT MANAGEMENT MARKET
- FIGURE 30. TOP PLAYER POSITIONING, 2023
- FIGURE 31. CVS HEALTH: NET SALES, 2021-2023 ($BILLION)
- FIGURE 32. CVS HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 33. CVS HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 34. THE CIGNA GROUP: NET SALES, 2021-2023 ($BILLION)
- FIGURE 35. THE CIGNA GROUP: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 36. THE CIGNA GROUP: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 37. OPTUMRX INC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 38. OPTUMRX INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 39. OPTUMRX INC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 40. ANTHEM INC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 41. ANTHEM INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 42. ANTHEM INC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 43. CENTENE CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 44. CENTENE CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 45. CENTENE CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 46. ABARCA HEALTH LLC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 47. ABARCA HEALTH LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 48. ABARCA HEALTH LLC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 49. MEDIMPACT: NET SALES, 2021-2023 ($BILLION)
- FIGURE 50. MEDIMPACT: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 51. MEDIMPACT: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 52. ELIXIR RX SOLUTIONS LLC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 53. ELIXIR RX SOLUTIONS LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 54. ELIXIR RX SOLUTIONS LLC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 55. EXPRESS SCRIPTS HOLDING COMPANY: NET SALES, 2021-2023 ($BILLION)
- FIGURE 56. EXPRESS SCRIPTS HOLDING COMPANY: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 57. EXPRESS SCRIPTS HOLDING COMPANY: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 58. SSANDC TECHNOLOGIES, INC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 59. SSANDC TECHNOLOGIES, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 60. SSANDC TECHNOLOGIES, INC: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook